Personalized biomedical devices have enormous potential to solve clinical challenges in urgent medical situations. Despite this potential, a device for in situ treatment of fatal seizures using pharmaceutical methods has not been developed yet. Here, we present a novel treatment system for neurological medical emergencies, such as status epilepticus, a fatal epileptic condition that requires immediate treatment, using a soft implantable drug delivery device (SID). The SID is integrated wirelessly with wearable devices for monitoring electroencephalography signals and triggering subcutaneous drug release through wireless voltage induction. Because of the wireless integration, bulky rigid components such as sensors, batteries, and electronic circuits can be moved from the SID to wearables, and thus, the mechanical softness and miniaturization of the SID are achieved. The efficacy of the prompt treatment could be demonstrated with animal experiments in vivo, in which brain damages were reduced and survival rates were increased.

Herein, underlying factors for enabling efficient and stable performance of perovskite solar cells are studied through nanostructural controls of organic−inorganic halide perovskites. Namely, MAPbI 3 , (FA 0.83 MA 0.17 )Pb(I 0.83 Br 0.17 ) 3 , and (Cs 0.10 FA 0.75 MA 0.15 )Pb(I 0.85 Br 0.15 ) 3 perovskites (abbreviated as MA, FAMA, and CsFAMA, respectively) are examined with a grain growth control through thermal annealing. FAMA-and CsFAMA-based cells result in stable photovoltaic performance, while MA cells are sensitively dependent on the perovskite grain size dominated by annealing time. Micro-/nanoscopic features are comprehensively analyzed to unravel the origin that is directly correlated to the cell performance with the applications of electronic-trap characterizations such as photoconductive noise microscopy and capacitance analyses. It is revealed that CsFAMA has a lower trap density compared to MA and FAMA through the analyses of 1/f noises and trapping/detrapping capacitances. Also, an open-circuit voltage (V oc ) change is correlated to the variation of trap states during the shelf-life test: FAMA and CsFAMA cells with the negligible change of V oc over weeks exhibit trap states shifting toward the band edge, although the power-conversion efficiencies are clearly reduced. The origins that critically affect the solar cell performance through the characterizations of shallow/deep traps with additional mobile defects in the perovskite and interfaces are discussed.

No abstract

The low delivery efficiency of light‐responsive theranostic nanoparticles (NPs) to target tumor sites, particularly to brain tumors due to the blood–brain barrier, has been a critical issue in NP‐based cancer treatments. Furthermore, high‐energy photons that can effectively activate theranostic NPs are hardly delivered to the target region due to the strong scattering of such photons while penetrating surrounding tissues. Here, a localized delivery method of theranostic NPs and high‐energy photons to the target tumor using microneedles‐on‐bioelectronics is presented. Two types of microneedles and flexible bioelectronics are integrated and mounted on the edge of surgical forceps. Bioresorbable microneedles containing theranostic NPs deliver the NPs into target tumors (e.g., glioblastoma, pituitary adenoma). Magnetic resonance imaging can locate the NPs. Then, light‐guiding/spreading microneedles deliver high‐energy photons from bioelectronics to the NPs. The high‐energy photons activate the NPs to treat tumor tissues by photodynamic therapy and chemotherapy. The controlled thermal actuation by the bioelectronics accelerates the diffusion of chemo‐drugs. The proposed method is demonstrated with mouse tumor models in vivo.